2026 NPPES data Adolescent Medicine (Internal Medicine) Physician NPI 1699093260 M.D.
Verify on CMS →

RIZWANA SULTANA, M.D.

Adolescent Medicine (Internal Medicine) Physician in GALVESTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
75
Medicare Part D claims · 14 beneficiaries · Adolescent Medicine (Internal Medicine) Physician avg: 3K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.9614/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$152.02
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RIZWANA SULTANA, M.D. reported a CMS MIPS final score of 74.9614/100 — below the 83.1 national average — and filed 75 Medicare Part D claims in 2023.

74.9614/100
MIPS score · -8 vs avg
75
Part D claims, 2023
85%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RIZWANA SULTANA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 12th percentile higher than 12% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

RIZWANA SULTANA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RIZWANA SULTANA, M.D.?

Below national average

NPI registry status

Active

Issued 05/06/2010

NPI 1699093260

Primary specialty

Adolescent Medicine (Internal Medicine) Physician

Rare

377 US NPIs in this specialty

Medicare Part D claims

75 98% vs specialty avg

2023 prescription claims

Specialty avg: 3,242

MIPS final score

74.9614/100 8.138599999999997% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Texas

How Adolescent Medicine (Internal Medicine) Physician compares to other specialties among Texas providers

Texas providers

Adolescent Medicine (Internal Medicine) Physician share within Texas

1. Adolescent Medicine (Internal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Adolescent Medicine (Internal Medicine) Physician share within Texas

Medicare quality performance — MIPS

RIZWANA SULTANA, M.D.'s 2023 MIPS final score plotted against the Adolescent Medicine (Internal Medicine) Physician national average

Below national average
MIPS Final Score
74.9614/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Adolescent Medicine (Internal Medicine) Physician) — 74.9614/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Adolescent Medicine (Internal Medicine) Physician) — 74.9614/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RIZWANA SULTANA, M.D. appears in the CMS NPPES registry as a Adolescent Medicine (Internal Medicine) Physician provider holding M.D. credentials at 301 UNIVERSITY BLVD, GALVESTON, TX, 77555, with a listed phone of (409) 772-2222. NPI 1699093260 was issued on 05/06/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SULTANA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 75 prescription claims written by this provider, covering 14 Medicare beneficiaries and totaling roughly $40K in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.9614/100 for the 2023 performance year (Quality 73.7789, Cost 47.7591), compared with the national average of 83.1.

Adolescent Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 377 enrolled providers across 46 states and an average of 3,242 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

301 UNIVERSITY BLVD
GALVESTON, TX 77555

Provider Details

NPI 1699093260
Specialty Adolescent Medicine (Internal Medicine) Physician
Credentials M.D.
Gender Female
NPI Issued 05/06/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

74.9614
Final Score
Avg: 83.1
73.7789
Quality
47.7591
Cost
94
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where RIZWANA SULTANA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UTMB FACULTY GROUP PRACTICE
ANGLETON, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RIZWANA SULTANA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$152

Largest payer

Inspire Medical Systems, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to RIZWANA SULTANA, M.D.. To verify RIZWANA SULTANA, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

RIZWANA SULTANA, M.D. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 75 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

75
Total Claims
$40K
Total Drug Cost
14
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
75
Total Day Supply
2,171
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$35K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
62.9 years
Avg HCC Risk Score
1.81

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RIZWANA SULTANA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Hydroxyzine Hcl
14
Modafinil
14
Doxepin Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Adolescent Medicine (Internal Medicine) Physician Overview

How RIZWANA SULTANA, M.D. fits within the Adolescent Medicine (Internal Medicine) Physician landscape nationally.

377
Adolescent Medicine (Internal Medicine) Physician Providers in US
46
States with Adolescent Medicine (Internal Medicine) Physician
3,242
Avg Claims per Provider

RIZWANA SULTANA, M.D.'s 75 claims are below the specialty average of 3,242.

Nearby Adolescent Medicine (Internal Medicine) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as SULTANA.

Compare Adolescent Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RIZWANA SULTANA, M.D.'s specialty?
RIZWANA SULTANA, M.D. specializes in Adolescent Medicine (Internal Medicine) Physician and practices in GALVESTON, Texas. Credentials: M.D..
How much does RIZWANA SULTANA, M.D. prescribe under Medicare Part D?
In 2023, RIZWANA SULTANA, M.D. wrote 75 Medicare Part D claims totaling $40K in drug costs for 14 beneficiaries.
What is RIZWANA SULTANA, M.D.'s Medicare quality score?
RIZWANA SULTANA, M.D. has a CMS MIPS Final Score of 74.9614/100 (Quality: 73.7789, Cost: 47.7591). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RIZWANA SULTANA, M.D. located?
RIZWANA SULTANA, M.D. is located at 301 UNIVERSITY BLVD, GALVESTON, TX, 77555. Phone: (409) 772-2222.
What is RIZWANA SULTANA, M.D.'s NPI number?
RIZWANA SULTANA, M.D.'s National Provider Identifier (NPI) is 1699093260, issued on 05/06/2010.
Does RIZWANA SULTANA, M.D. prescribe more brand-name or generic drugs?
RIZWANA SULTANA, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $35K in brand drug costs.
How many Adolescent Medicine (Internal Medicine) Physician providers are there in the US?
There are 377 Adolescent Medicine (Internal Medicine) Physician providers across 46 states in the US. The average Adolescent Medicine (Internal Medicine) Physician provider writes 3,242 Medicare Part D claims per year.
What drugs does RIZWANA SULTANA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RIZWANA SULTANA, M.D.'s most frequently prescribed drugs include Hydroxyzine Hcl, Modafinil, Doxepin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RIZWANA SULTANA, M.D. accept Medicare?
RIZWANA SULTANA, M.D. appears in CMS Medicare data with 75 Part D claims and 14 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RIZWANA SULTANA, M.D.'s credentials?
RIZWANA SULTANA, M.D.'s NPI is 1699093260 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology